Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: Valbiotis

Market Cap 20.63M 23.48M 19.01M 17.79M 33.36M 2.22B 33.96M 229M 88.28M 1.09B 88.13M 86.21M 3.79B P/E 2026 *
-2.31x
P/E 2027 * -6.71x
Enterprise Value 21.83M 24.84M 20.11M 18.82M 35.3M 2.35B 35.94M 242M 93.42M 1.15B 93.26M 91.23M 4.01B EV / Sales 2026 *
5.67x
EV / Sales 2027 * 1.41x
Free-Float
64%
Yield 2026 *
-
Yield 2027 * -
1 day+1.63%
1 week-0.68%
Current month-24.44%
1 month-16.63%
3 months-18.66%
6 months+32.72%
Current year+25.65%
1 week 0.83
Extreme 0.831
0.9
1 month 0.83
Extreme 0.831
1.25
Current year 0.65
Extreme 0.653
1.3
1 year 0.54
Extreme 0.535
1.3
3 years 0.54
Extreme 0.535
7.5
5 years 0.54
Extreme 0.535
7.5
10 years 0.54
Extreme 0.535
10.65
Manager TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - 29/02/2024
Chief Tech/Sci/R&D Officer - 31/08/2017
Director TitleAgeSince
Chairman 55 28/02/2017
Director/Board Member - 25/10/2017
Director/Board Member - 17/03/2019
Date Insider Type Main position Quantity % Market Cap.
27/01/22Fiscal year

Founder

2,095 0.0215%
27/01/22Others

Founder

42,480 0.4364%
09/07/21Fiscal year

Chief Technology Officer

10,000 0.1030%
Change 5-day change 1-year change 3-year change Capi.($)
+1.63%-0.68%-0.46%-78.52% 23.23M
+2.14%+6.81%+72.57%+123.91% 56.65B
-0.49%+6.98%+62.88%+67.95% 47.49B
+0.48%-0.20%-14.93%-15.55% 22.81B
+3.60%+4.81%-0.52%+402.21% 21.37B
+1.30%+0.71%+29.21%-17.51% 16.12B
+3.20%+7.18%+24.07%-34.39% 15.56B
-0.02%-3.13%+27.17%+158.25% 12.91B
0.00%+15.02%+133.24%+273.89% 12.86B
+1.43%-5.06%+23.53% - 11.67B
Average +1.33%+1.34%+35.68%+97.80% 21.75B
Weighted average by Cap. +1.26%+3.17%+45.66%+112.90%

Financials

2026 *2027 *
Net sales 3.85M 4.38M 3.55M 3.32M 6.23M 415M 6.34M 42.66M 16.48M 204M 16.45M 16.09M 708M 13.3M 15.14M 12.25M 11.47M 21.51M 1.43B 21.9M 147M 56.92M 703M 56.82M 55.58M 2.45B
Net income -8.85M -10.07M -8.15M -7.63M -14.31M -954M -14.57M -98.06M -37.87M -468M -37.81M -36.99M -1.63B -5.4M -6.15M -4.98M -4.66M -8.73M -582M -8.89M -59.83M -23.11M -285M -23.07M -22.57M -993M
Net Debt 1.2M 1.37M 1.11M 1.03M 1.94M 129M 1.98M 13.3M 5.14M 63.44M 5.13M 5.02M 221M -1.9M -2.16M -1.75M -1.64M -3.07M -205M -3.13M -21.05M -8.13M -100M -8.12M -7.94M -349M
Logo Valbiotis
VALBIOTIS is a French laboratory specializing in the creation and distribution of dietary supplements scientifically tested to maintain health at every stage of life. Through an innovative approach combining scientific excellence, plant expertise and a wealth of natural ingredients, VALBIOTIS offers a new generation of dietary supplements to support cardio-metabolic balance and well-being, and address everyday health issues such as sleep, fatigue, mood management, immunity and vitality.
Employees
50
Date Price Change Volume
23/06/26 €0.8720 +1.63% 133,369
22/06/26 €0.8580 -0.69% 188,435
19/06/26 €0.8640 -2.70% 40,429
18/06/26 €0.8880 +0.11% 146,005
17/06/26 €0.8870 +0.68% 47,545
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
0.8720EUR
Average target price
2.378EUR
Spread / Average Target
+172.66%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ALVAL Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!